The appearance of psoriasis can vary based on the level of melanin, or the pigment that colors our skin. For Black patients or those with darker pigmented skin, lesions may be violet, dark brown ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses strategies to address underrepresentation in clinical trials, particularly in phase III psoriasis trials.

LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving ...

Despite this widespread use, it is remarkable that only 40% of patients disclosed their use of CAM products to their providers (Eisenberg et al., 1998; Helwig, 2000; Stein, 2000). Psoriasis ...

There is higher risk for cardiovascular complications during delivery in pregnant patients with psoriasis compared with patients without psoriasis.

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study. The randomized ...